No Data
No Data
Microelectrophysiology (688351.SH) plans to purchase real estate assets located in Zhoupu Town, Shanghai.
Microelectrophysiology (688351.SH) released an announcement that its wholly-owned subsidiary Shanghai Zidian Medical Technology Co., Ltd. (abbreviated...
Microelectrophysiology (688351.SH): Zidian Medical plans to sign a "House Sale Contract" with Shanghai Orthopedics.
On December 11, Gelonghui reported that Microelectrophysiology (688351.SH) announced that Zidian Medical intends to sign a "Real Estate Sale Contract" with Shanghai Orthopedics to purchase the usage rights of the property located at 1-28 Building 23, Tianxiong Road, Zhoupu Town, Shanghai, as well as 7 underground parking spaces. This is intended for the production of catheter products and to expand its own storage space. The transaction price is based on the assessment results provided by the asset evaluation agency and is agreed upon through negotiation to be 48.5 million yuan (excluding tax). The funding for this asset purchase will come from its own funds.
Micro-electrophysiology (688351): Rapid growth in three-dimensional surgery, comprehensive development of the cryoablation and radiofrequency energy platform.
Deeply cultivating the electrophysiology track, the product has a comprehensive layout. Microelectrophysiology was established in 2010, based on the empowerment of MicroPort group. The company has deeply laid out around the electrophysiology track, and has now formed a complete layout of equipment + mapping catheter + ablation catheter, ablation technology.
Microport EP (stock code: 688351): Centralized procurement accelerates product delivery, and the progress of pulse ablation is smooth.
Event: On the evening of October 21st, the company released the third quarter report of 2024: In the first three quarters of 2024, revenue reached 0.291 billion yuan, a year-on-year increase of 23.21%; net income attributable to the parent company was 0.042 billion yuan, year-on-year
Microelectronics-U (688351): Short-term performance affected by distributor adjustment and delayed revenue recognition, high-end product volume can be expected.
Microelectronics released its Q3 2024 report. In 2024 Q1-Q3, it achieved revenue of 0.291 billion yuan, a year-on-year growth of 23.21%; net profit attributable to mothers was 41.73 million yuan, a year-on-year growth of 262.22%; after deducting non-recurring items.
Microelectrophysiology (stock code: 688351): Significant increase in new product additions, significant increase in company's net margin.
Performance Summary The company released the third quarter report for 2024, achieving revenue of 0.291 billion yuan in the first three quarters, a year-on-year increase of 23.21%; achieving a net income attributable to the parent company of 41.73 million yuan, a year-on-year increase of 262.22%; achieving non-recurring